Lentiviral Gene Therapy Shows Promise in Severe Hemophilia A

Published Date: 13 Dec 2024

Increased factor VIII levels to mild or moderate range, with annualized bleeding rate of zero

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Novel Agent for Chronic GVHD Wins FDA Approval

2.

In SCLC, Radiotherapy Plus Immunotherapy Ups Fatal Events

3.

Including Bereavement in the Care Continuum.

4.

Study Hints at Survival Benefit With Transplant for Metastatic Lung Cancer

5.

Taking Charge of Your Cancer Journey.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot